Strides Pharma, Inc is recalling over 4.4 lakh cartons of Testosterone Gel in the US market due to the presence of a foreign substance, according to the US Food and Drug Administration.
The Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene', USFDA said.
The company initiated the Class II recall on March 5 this year.
A Class II recall means that the use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote.